title: SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions.
authors.affiliation: Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Kwee
authors.forename: Gang
authors.initials: G
authors.lastname: Cheng
authors.forename: Marnix G E H
authors.initials: MG
authors.lastname: Lam
authors.forename: Sandip
authors.initials: S
authors.lastname: Basu
authors.forename: Abass
authors.initials: A
authors.lastname: Alavi
mesh_terms: D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D011485:Protein Binding; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012015:Reference Standards
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18